While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...

Innovent is a leading biotech company in China with strong roots in oncology, anchored by its core PD-1 drug Tyvyt. The price cut for PD-1 drugs has stabilized gradually. Hence, we expect stable ...

L&T Finance Ltd. (LTF), one of the leading Non-Banking Financial Company (NBFC), today has named renowned Indian cricketer ...

MSCI ESG Ratings is the main reference at the global level to assess the extent to which a company or institution applies ...

Global technology corporation FPT has secured the EcoVadis Silver rating for its Japanese subsidiary for the second ...